Our study revealed an independent correlation between subclinical atherosclerosis and serum lipocalin-2 and RBP4 levels in type 2 diabetic patients, suggesting that these lipocalins might be involved in the early stage of diabetic vascular complications. Here, LCN2 is linked to atherosclerosis.